Results 191 to 200 of about 112,374 (313)

Machine learning‐based prediction of elevated N terminal pro brain natriuretic peptide among US general population

ESC Heart Failure, Volume 12, Issue 2, Page 859-868, April 2025.
Abstract Aims Natriuretic peptide‐based pre‐heart failure screening has been proposed in recent guidelines. However, an effective strategy to identify screening targets from the general population, more than half of which are at risk for heart failure or pre‐heart failure, has not been well established.
Yuichiro Mori, Shingo Fukuma, Kyohei Yamaji, Atsushi Mizuno, Naoki Kondo, Kosuke Inoue   +5 more
wiley   +1 more source

Coronary Artery Disease Doubles Excess Mortality in Patients With Heart Failure With Reduced Ejection Fraction. [PDF]

J Am Heart Assoc
Anker N, Olesen KKW, Thrane PG, Gyldenkerne C, Mortensen MB, Nielsen RR, Løgstrup BB, Würtz M, Nielsen JC, Maeng M.   +9 more
europepmc   +1 more source

Comprehensive exploration of unexplained dyspnoea in subjects with normal ejection fraction and low natriuretic peptides

ESC Heart Failure, Volume 12, Issue 2, Page 879-887, April 2025.
Abstract Background Unexplained exertional dyspnoea without significant elevation of natriuretic peptides is common. One of the causes might be early heart failure with preserved ejection fraction (HFpEF). Aims This study aimed to characterize patients with exertional dyspnoea and normal/near‐to‐normal N‐terminal pro‐brain natriuretic peptide (NT ...
Emmanuelle Berthelot, Tarek Laouar, Antoine Beurnier, Nataliya Hrynchynshyn, Jean Christophe Eicher, Jean‐Michel Tartière, Patrick Jourdain, Olivier Lairez, Barnabas Gellen   +8 more
wiley   +1 more source

Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency [PDF]

, 2017
Gregory D. Lewis, Rajeev Malhotra, Adrian F. Hernandez, Steven E. McNulty, Andrew L. Smith, G. Michael Felker, W.H. Wilson Tang, Shane LaRue, Margaret M. Redfield, Marc J. Semigran, Michael M. Givertz, Peter Van Buren, David J. Whellan, Kevin J. Anstrom, Monica Shah, Patrice Desvigne‐Nickens, Javed Butler, Eugene Braunwald   +17 more
openalex   +1 more source

Growth differentiation factor‐15 and N‐terminal pro‐BNP in acute heart failure with preserved ejection fraction

ESC Heart Failure, Volume 12, Issue 2, Page 888-899, April 2025.
Abstract Aims Heart failure with preserved ejection fraction (HFpEF) continues to be an increasingly common health problem associated with a high mortality rate. Elevated levels of Growth differentiation factor‐15 (GDF15) and N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) are reportedly associated with poor clinical outcomes in a broad range of ...
Yoichiro Otaki, Tetsu Watanabe, Mari Shimizu, Shingo Tachibana, Junya Sato, Yuta Kobayashi, Harutoshi Tamura, Shigehiko Kato, Satoshi Nishiyama, Hiroki Takahashi, Takanori Arimoto, Masafumi Watanabe   +11 more
wiley   +1 more source

Clinical Impact of the Early Use of Sacubitril/Valsartan in Newly Diagnosed Heart Failure and Reduced Ejection Fraction. [PDF]

Acta Cardiol Sin
Hsu TJ, Hsiao FC, Chan CC, Chuang C, Chu PH, Ko YS.   +5 more
europepmc   +1 more source

The role of cardiac acoustic biomarkers in monitoring patients with heart failure: A systematic literature review

ESC Heart Failure, Volume 12, Issue 2, Page 980-997, April 2025.
Abstract Heart failure (HF) creates a considerable clinical, humanistic and economic burden on patients and caregivers as well as on healthcare systems. To attenuate the significant burden of HF, there is a need for enhanced management of patients with HF.
Javed Butler, Malcolm Brown, Philippe Prokocimer, Ashley C. Humphries, Sophie Pope, Olivia Wright, Jun Su, Osama Elnawasany, Bogdan Muresan   +8 more
wiley   +1 more source

Erythrocytosis incidence and thromboembolic risk in heart failure with reduced ejection fraction treated with SGLT2 inhibitors: a nationwide register-based cohort study. [PDF]

Cardiovasc Diabetol
Mohamed AA, Andersen CF, Christensen DM, Riis-Vestergaard LD, Mohammad M, Elmegaard M, Binding C, Torp-Pedersen C, Biering-Sørensen T, Hansen ML, Køber L, Glenthøj A, Jensen J, Andersson C, Schou M, Gislason G.   +15 more
europepmc   +1 more source

Medical therapy of heart failure with reduced ejection fraction: current evidence and new developments

Swiss Medical Weekly, 2016
Matthias Naegele, Andreas J Flammer, Frank Enseleit, Frank Ruschitzka   +3 more
doaj   +1 more source

Early prescription of quadruple therapy in acute decompensated heart failure with reduced ejection fraction: A propensity score-matched analysis. [PDF]

ESC Heart Fail
Echeverría LE, Rojas LZ, Serrano-García AY, Botero D, García-Rueda KA, Torres-Bustamante Á, Cañón-Gómez DI, Salcedo JS, Hurtado-Ortiz A, Rodríguez JA, Gómez-Ochoa SA.   +10 more
europepmc   +1 more source